Automation and scale-up of human induced pluripotent stem cell models of cardiovascular disease for drug screening

QR Code

Automation and scale-up of human induced pluripotent stem cell models of cardiovascular disease for drug screening

The global cost of heart failure is USD$45 billion and set to double in the next 15 years. The only method of treatment is heart transplant but demand far exceeds supply and is projected to increase. Meanwhile, global pharmaceutical development has been hindered by poor drug development success rate...

Full description

Bibliographic Details
Main Author:	Crutchley, James E.B.
Format:	Thesis (University of Nottingham only)
Language:	English English English English English English English English English English English English English English English English English English
Published:	James Crutchley 2016
Subjects:	Stem Cells Robotics Automation Cardiomyocytes Drug screening Human induced pluripotent stem cells Doxorubicin
Online Access:	https://eprints.nottingham.ac.uk/32207/

Similar Items

Current status of drug screening and disease modelling in human pluripotent stem cells
by: Rajamohan, Divya, et al.
Published: (2013)

Evaluating human induced pluripotent stem cell-derived cardiomyocytes for commercial drug testing
by: Katili, Puspita Anggraini
Published: (2020)

Generation of mouse induced pluripotent stem cells using polycistronic lentiviral vector in feeder - and serum-free culture
by: Mahmaud, Akram Faisal
Published: (2015)

Human pluripotent stem cells derived-cardiomyocytes (hPSC-CMs) to assess the impact of drug- and gene-induced changes on cell function
by: Mohd Yusof, Nurul Ain Nasim
Published: (2020)

Using human induced pluripotent stem cells to study the in vitro phenotype of the cardiac channelopathies
by: Duncan, Gary
Published: (2017)

Directed differentiation of human induced pluripotent stem cells into functional cholangiocyte-like cells
by: Sampaziotis, Fotios, et al.
Published: (2017)

Induced pluripotent stem cells from human hair follicle keratinocytes as a potential source for in vitro hair follicle cloning
by: Lim, Sheng Jye, et al.
Published: (2016)

Development of a human induced pluripotent stem cells (hiPSCs)-derived, universal platform, for generation of immunocompetent multi-tissue organoids
by: Azis, Rizal
Published: (2024)

Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation
by: Dixon, James E., et al.
Published: (2014)

Investigating heparan sulphate in development using human pluripotent stem cells
by: Thompson, Jamie
Published: (2022)

Materials for stem cell factories of the future
by: Celiz, Adam D., et al.
Published: (2014)

Discovery of a novel polymer for human pluripotent stem cell expansion and multilineage differentiation
by: Celiz, Adam D., et al.
Published: (2015)

Cardiomyocytes from human pluripotent stem cells: from laboratory curiosity to industrial biomedical platform
by: Denning, Chris, et al.
Published: (2016)

Gene expression network analysis of the routes to pluripotency
by: Amaral, Fabio M R
Published: (2018)

Improving the maturation of human pluripotent stem cell - derived hepatocyte-like cells using an automated-design of experiments approach
by: Fotopoulos, Lazaros
Published: (2019)

Evaluation of minicircle-induced pluripotent stem cell
by: Daneshvar, Nasibeh
Published: (2014)

Simplified footprint-free Cas9/CRISPR editing of cardiac-associated genes in human pluripotent stem cells
by: Kondrashov, Alexander, et al.
Published: (2018)

Can human pluripotent stem cell-derived cardiomyocytes advance understanding of muscular dystrophies?
by: Kalra, Spandan, et al.
Published: (2016)

Developing a chemically defined, xeno-free platform to differentiate human induced pluripotent stem cells to type 2 alveolar epithelial cells of the lung
by: Reed, Liam
Published: (2024)

Generation, propagation and characterization of second and full-term amniotic fluid-derived mesenchymal stem cell
by: Ghoraishizadeh, Peyman
Published: (2016)

Engineered human pluripotent stem cell derived cardiomyocyte platforms to detect cardiovascular safety liabilities
by: Firth, Karl
Published: (2017)

MUSCLEMOTION: a versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo
by: Sala, L., et al.
Published: (2017)

A defined synthetic substrate for serum-free culture of human stem cell derived cardiomyocytes with improved functional maturity identified using combinatorial materials microarrays
by: Patel, Asha K., et al.
Published: (2015)

Exploring the immunomodulatory effects of human mesenchymal stem cells on monocyte functions
by: Maqbool, Maryam
Published: (2016)

In vitro modelling of respiratory infections in idiopathic pulmonary fibrosis (IPF) using human induced pluripotent stem cell (hiPSCs)-derived alveolar epithelial type II cells
by: Serna Valverde, Ana Lilia
Published: (2023)

Immunomodulatory Effects of Human Mesenchymal Stem Cells on Neutrophil Functions
by: Maqbool, Maryam
Published: (2011)

Generation and Characterisation of Mesenchymal Stem Cells Derived from Placenta and Adult Cardiac Tissue
by: Vellasamy, Shalini
Published: (2011)

Developing an automation-compatible quantitative and functional assay for the assessment of pluripotency
by: Flatt, Luke
Published: (2017)

Improving the mesodermal differentiation potential of human embryonic stem cells
by: Burridge, Paul Wesley
Published: (2008)

Generation and characterization of human cardiac resident and non-resident mesenchymal stem cell
by: Subramani, Baskar, et al.
Published: (2016)

Applications of Raman micro-spectroscopy to stem cell technology: label-free molecular discrimination and monitoring cell differentiation.
by: Ghita, Adrian, et al.
Published: (2015)

Anti-tumour efficacy of human mesenchymal stem cell expressing trail on lung cancer cell lines-derived cancer stem cell
by: Shaik M Fakiruddin, Shaik Ahmad Kamal
Published: (2021)

Disease modeling hypertrophic cardiomyopathy using CRISPR/Cas9 genome editing technology in human pluripotent stem cell-derived cardiomyocytes
by: Mosqueira, Diogo
Published: (2018)

Differentiation of skeletal muscle-derived stem cells into beta pancreatic lineage
by: Yeo, Wendy Wai Yeng
Published: (2015)

A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells
by: Warrier, S, et al.
Published: (2013)

CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy
by: Mosqueira, Diogo, et al.
Published: (2018)

In vitro antiproliferative activity of HT-29 and HL-60 cells, and proliferative activity of MSC treated with Channa striatus bloch crude extracts
by: Mohd Jamil, Nur Syamsyiah
Published: (2012)

The potential utility of stem cells in the treatment of congenital heart disease
by: Davies, Ben
Published: (2009)

Establishment of the human cardiac models using gene editing and reprogramming in Human Pluripotent Stem Cells to understand the putative functions of the G-protein coupled receptor kinase 5 polymorphism (GRK5-L41)
by: Hoang, Minh Duc
Published: (2017)

An investigation into the function and mechanism of a GRK5-L41 polymorphism using human pluripotent cell-derived cardiomyocytes
by: Vo, Nguyen T. N.
Published: (2021)